CranioSacral Therapy for Parkinson's Disease
Trial Summary
What is the purpose of this trial?
We are studying \& researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.
Research Team
Al Raza, CST
Principal Investigator
IBR, Inc.
Eligibility Criteria
This trial is for individuals who have been diagnosed with Parkinson's Disease. It aims to include those specifically suffering from this condition and excludes anyone who does not have Parkinson's Disease.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive CranioSacral Integrative therapy for Parkinson's Disease, with biweekly sessions lasting 90 minutes each over 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Biweekly Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zia, Al Raza
Lead Sponsor